During the screening of small molecules that regulate obesity-related metabolic syndrome, BZ26, a novel GW9662 derivate that was identified as a potential ligand of PPARγ via molecular docking studies (Bei et al., 2016). The gene discussed is PPARG; the disease is obesity disorder.